Cameroon vs Canada: Access to anti-retroviral drugs, male
Cameroon
79.0%
in 2024
Canada
78.0%
in 2022
Cameroon rank
49th
Canada rank
51st
Access to anti-retroviral drugs, male over time
- Cameroon
- Canada
How they compare
Cameroon currently reports 79.0% against 78.0% in Canada, a difference of 1.0%.
Across all 23 years both countries report, Canada has been ahead every year.
Cameroon ranks 49th and Canada ranks 51st of 141 countries.
Canada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cameroon | Canada | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.7% | 32.0% | 27.3% | Canada |
| 2010s | 26.0% | 64.5% | 38.5% | Canada |
| 2020s | 62.0% | 79.0% | 17.0% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Cameroon or Canada?
- Cameroon, at 79.0% against 78.0% in Canada as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Cameroon and Canada?
- 1.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Canada?
- 23 years are reported by both, from 2000 to 2022.
- How do Cameroon and Canada rank globally for access to anti-retroviral drugs, male?
- Cameroon ranks 49th and Canada ranks 51st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.